These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing. Hart M, Nolte E, Wach S, Szczyrba J, Taubert H, Rau TT, Hartmann A, Grässer FA, Wullich B. Mol Cancer Res; 2014 Feb; 12(2):250-63. PubMed ID: 24337069 [Abstract] [Full Text] [Related]
4. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K. Int J Cancer; 2010 Mar 01; 126(5):1166-76. PubMed ID: 19676045 [Abstract] [Full Text] [Related]
10. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Chen ZH, Zhang GL, Li HR, Luo JD, Li ZX, Chen GM, Yang J. Prostate; 2012 Sep 15; 72(13):1443-52. PubMed ID: 22298030 [Abstract] [Full Text] [Related]
16. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM. Lancet Oncol; 2015 Jul 15; 16(7):804-15. PubMed ID: 26088272 [Abstract] [Full Text] [Related]
18. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases. Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K. Ann Surg Oncol; 2014 Mar 15; 21(3):1046-54. PubMed ID: 24242678 [Abstract] [Full Text] [Related]